Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 1;107(12):2983-2987.
doi: 10.3324/haematol.2022.281431.

Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort

Affiliations

Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort

Magali Colombat et al. Haematologica. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Tissue/organ tropism and identification rate of the amyloid protein per tissue/organ. The tissue/organ distribution of the 19 amyloid types identified in the present study is illustrated in decreasing order of frequency. Among the 26 tissue/organs analyzed herein, the 5 most commonly (67.5% of cases) analyzed anatomic sites were secondary salivary glands (21.0%), heart (17.2%), lung (10.8%), gastrointestinal tract (9.4%), and kidney (9.1%). Fat aspirate/biopsy was not analyzed in this series because this procedure is not as commonly performed in France as in other countries. The diversity of the amyloid types was greater in the kidney and the heart with 10 and 6 different types identified, respectively. The amyloid protein identification rate (IR) is reported for each of the 26 tissues/organs. CNS: central nervous system; GI tract: gastrointestinal tract; PTH: parathyroid hormon.

References

    1. Benson MD, Buxbaum JN, Eisenberg DS, et al. . Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2020;27(4):217-222. - PubMed
    1. Muchtar E, Dispenzieri A, Magen H, et al. . Systemic amyloidosis from A (AA) to T (ATTR): a review. J Intern Med. 2021;289(3):268-292. - PubMed
    1. Picken MM. The Pathology of amyloidosis in classification: a review. Acta Haematol. 2020;143(4):322-334. - PubMed
    1. Satoskar AA, Efebera Y, Hasan A, et al. . Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing. Am J Surg Pathol. 2011;35(11):1685-1690. - PMC - PubMed
    1. Gonzalez Suarez ML, Zhang P, Nasr SH, et al. . The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry. Kidney Int. 2019;96(4):1005-1009. - PubMed

Publication types